ALPRE Stock Overview
Develops and sells medical techniques and mathematical models. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Predilife S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €3.64 |
| 52 Week High | €24.00 |
| 52 Week Low | €3.32 |
| Beta | 0.35 |
| 1 Month Change | -15.35% |
| 3 Month Change | -25.10% |
| 1 Year Change | -37.78% |
| 3 Year Change | -49.09% |
| 5 Year Change | -53.92% |
| Change since IPO | -60.86% |
Recent News & Updates
Recent updates
Shareholder Returns
| ALPRE | FR Biotechs | FR Market | |
|---|---|---|---|
| 7D | -3.7% | -2.5% | -1.7% |
| 1Y | -37.8% | -30.5% | -4.8% |
Return vs Industry: ALPRE underperformed the French Biotechs industry which returned -30.5% over the past year.
Return vs Market: ALPRE underperformed the French Market which returned -4.8% over the past year.
Price Volatility
| ALPRE volatility | |
|---|---|
| ALPRE Average Weekly Movement | 7.0% |
| Biotechs Industry Average Movement | 7.1% |
| Market Average Movement | 4.5% |
| 10% most volatile stocks in FR Market | 9.7% |
| 10% least volatile stocks in FR Market | 2.3% |
Stable Share Price: ALPRE's share price has been volatile over the past 3 months compared to the French market.
Volatility Over Time: ALPRE's weekly volatility has decreased from 32% to 7% over the past year, but is still higher than 75% of French stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2004 | 19 | Stephane Ragusa | www.predilife.com |
Predilife S.A. develops and sells medical techniques and mathematical models. The company provides prevention and breast check-up tests. Its products include MammoRisk, a test for predicting the development of breast cancer based on the patient’s individual risk; and DenSeeMammo, a breast density measurement software, as well as a medical device for the prediction of prostate cancer risk.
Predilife S.A. Fundamentals Summary
| ALPRE fundamental statistics | |
|---|---|
| Market cap | €13.53m |
| Earnings (TTM) | -€4.66m |
| Revenue (TTM) | €300.87k |
45.0x
P/S Ratio-2.9x
P/E RatioIs ALPRE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ALPRE income statement (TTM) | |
|---|---|
| Revenue | €300.87k |
| Cost of Revenue | -€920.84k |
| Gross Profit | €1.22m |
| Other Expenses | €5.88m |
| Earnings | -€4.66m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.25 |
| Gross Margin | 406.06% |
| Net Profit Margin | -1,548.80% |
| Debt/Equity Ratio | -128.1% |
How did ALPRE perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 06:43 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Predilife S.A. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jean-Pierre Loza | In Extenso Financement & Marché |